INTERVIEW-Blockbuster hopes grow for Ablynx drug backed by AbbVie

July 7 (Reuters) - Ablynx's hopes for a potential
multibillion-dollar drug were boosted on Thursday by strong
clinical trial results in rheumatoid arthritis, vindicating a
$175 million bet placed on...